Fetal echocardiography is a test that uses sound waves ( ultrasound ) to evaluate the baby's heart for problems before birth.
Ultrasound uses high-frequency sound waves to make images of organs and structures inside the body.
How the Test is Performed
Fetal echocardiography is a test that is done while the baby is still in the womb. It is most often done during the second trimester of pregnancy. This is when a woman is about 18 to 24 weeks pregnant.
The procedure is similar to that of a pregnancy ultrasound . You will lie down for the procedure.
A pregnancy ultrasound is an imaging test that uses sound waves to create a picture of how a baby is developing in the womb. It is also used to chec...
The test can be performed on your belly (abdominal ultrasound) or through your vagina ( transvaginal ultrasound ).
Transvaginal ultrasound is a test used to look at a woman's uterus, ovaries, tubes, cervix and pelvic area. Transvaginal means across or through the ...
In an abdominal ultrasound, the person performing the test places a clear, water-based gel on your belly. A hand-held probe is moved over the area. The probe sends out sound waves, which bounce off the baby's heart and create a picture of the heart on a computer screen.
In a transvaginal ultrasound, a much smaller probe is placed into the vagina. A transvaginal ultrasound can be done earlier in the pregnancy and produces a clearer image than an abdominal ultrasound.
How to Prepare for the Test
No special preparation is needed for this test.
How the Test will Feel
The conducting gel may feel slightly cold and wet. You will not feel the ultrasound waves.
Why the Test is Performed
This test is done to detect a heart problem before the baby is born. It can provide a more detailed image of the baby's heart than a regular pregnancy ultrasound.
The test can show:
- Blood flow through the heart
- Heart rhythm
- Structures of the baby's heart
The test may be done if:
- A sibling or other family member had a heart defect or heart disease.
- A routine pregnancy ultrasound detected an abnormal heart rhythm or possible heart problem in the unborn baby.
The mother has
type 1 diabetes
Type 1 diabetes
Type 1 diabetes is a lifelong (chronic) disease in which there is a high level of sugar (glucose) in the blood.
Systemic lupus erythematosus (SLE) is an autoimmune disease. In this disease, the body's immune system mistakenly attacks healthy tissue. It can af...
- The mother has rubella during pregnancy.
- The mother has used medicines that can damage the baby's developing heart (such as some epilepsy drugs and prescription acne medications).
- An amniocentesis revealed a chromosome disorder.
The echocardiogram finds no problems in the unborn baby's heart.
What Abnormal Results Mean
Abnormal results may be due to:
- A problem in the way the baby's heart has formed ( congenital heart disease )
- A problem with the way the baby's heart works
- Heart rhythm disturbances ( arrhythmias )
The test may need to be repeated.
There are no known risks to the mother or unborn baby.
Some heart defects cannot be seen before birth, even with fetal echocardiography. These include small holes in the heart or mild valve problems. Also, because it may not be possible to see every part of the large blood vessels leading out of the baby's heart. Therefore, problems in this area may go undetected.
If the health care provider finds a problem in the structure of the heart, a detailed ultrasound may be done to look for other problems with the developing baby.
Donofrio MT et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation . 2014 May 27;129(21):2183-242. PMID: 24763516 www.ncbi.nlm.nih.gov/pubmed/24763516 .
Maeno Y, Hirose A, Kanbe T, Hori D. Fetal arrhythmia: prenatal diagnosis and perinatal management. J Obstet Gynaecol Res . 2009 Aug;35(4):623-9. PMID: 19751319 www.ncbi.nlm.nih.gov/pubmed/19751319 .
Review Date: 1/12/2015
Reviewed By: Kimberly G Lee, MD, MSc, IBCLC, Associate Professor of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, SC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.